Rocket Lab USA, Inc. (NASDAQ: RKLB) is a Industrials company in the Aerospace & Defense industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | NDX | P/E | - | EPS (ttm) | -0.33 | Insider Own | - | Shs Outstand | 578.87M | Perf Week | 1.63% |
| Market Cap | 37.60B | Forward P/E | - | EPS next Y | 0.00 | Insider Trans | -1.14% | Shs Float | 539.07M | Perf Month | -35.10% |
| Enterprise Value | 36.53B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 8.51% | Perf Quarter | -21.28% |
| Income | -172.95M | P/S | 55.32 | EPS this Y | 41.17% | Inst Trans | - | Short Ratio | 1.69 | Perf Half Y | -24.19% |
| Sales | 679.58M | P/B | 17.37 | EPS next Y | 99.47% | ROA | -6.48% | Short Interest | 45.85M | Perf YTD | -6.90% |
| Book/sh | - | P/C | - | EPS next 5Y | - | ROE | -12.26% | 52W High | 163.75 -56.99% | Perf Year | 39.86% |
| Cash/sh | - | P/FCF | - | EPS past 3/5Y | - | ROIC | -8.07% | 52W Low | 40.74 72.88% | Perf 3Y | 809.66% |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | 41.83% 76.65% | Gross Margin | 36.56% | Volatility | 8.02% 7.28% | Perf 5Y | 503.06% |
| Dividend TTM | - | EV/Sales | 53.75 | EPS Y/Y TTM | 13.16% | Oper. Margin | -33.20% | ATR (14) | 6.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.02 | Sales Y/Y TTM | 55.73% | Profit Margin | -26.87% | RSI (14) | 37.73 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.47 | EPS Q/Q | 83.33% | SMA20 | -10.27% | Beta | 2.58 | Target Price | 114.00 |
| Payout | 0.00% | Debt/Eq | 0.06 | Sales Q/Q | 62.60% | SMA50 | -32.88% | Rel Volume | 0.51 | Prev Close | 64.95 |
| Employees | 2,600 | LT Debt/Eq | 0.15 | Earnings | Aug 10 | SMA200 | -16.49% | Avg Volume | 26.37M | Price | 70.43 |
| IPO Date | Nov 24, 2020 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 70.18% 5.64% | Net Debt/EBITDA | 7.01 | Volume | 13,437,971 | Change | 8.44% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-27-26 | Upgrade | KGI Securities | Neutral → Outperform | $105 → $107 |
| Jul-15-26 | Initiated | Piper Sandler | Neutral | $83 |
| Jun-15-26 | Upgrade | Keybanc | Sector Weight → Overweight | $75 → $135 |
| Jun-11-26 | Initiated | KGI Securities | Neutral | $105 |
| Jun-04-26 | Reiterated | Stifel Nicolaus | $105 → $132 | |
| May-12-26 | Reiterated | Deutsche Bank | Buy | $12 → $120 |
| May-08-26 | Reiterated | Craig-Hallum | $98 | |
| Apr-20-26 | Reiterated | Stifel Nicolaus | $90 → $105 | |
| Apr-17-26 | Reiterated | Roth Capital | Buy | $75 → $100 |
| Apr-07-26 | Upgrade | Citizens | Market Perform → Market Outperform |
Headquartered in Long Beach, California, Rocket Lab USA, Inc. is a prominent aerospace firm established in 2006. This company delivers a comprehensive suite of space-related services and hardware, primarily catering to the space and defense industries. Their operations encompass orbital launch capabilities, advanced spacecraft engineering and construction, production of various spacecraft components, and sophisticated on-orbit management services, including full constellation management. Rocket Lab is known for developing and producing a range of launch vehicles, from small to medium-class rockets. Key products include the highly successful Electron small orbital launch vehicle and the versatile Photon satellite platforms, both of which they design, manufacture, and market. Furthermore, the company is actively developing the larger Neutron launch vehicle, capable of carrying 8-ton payloads. Beyond manufacturing, they also conduct remote launch operations and craft specialized components and subsystems for both their Photon spacecraft family and the broader commercial spacecraft market. Their diverse clientele spans commercial enterprises, major aerospace contractors, and governmental entities.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 679 | 602 | 436 | 245 | 211 | 62 | 35 | 48 | |
| Cost of Goods Sold Incl. D&A | 431 | 395 | 320 | 193 | 192 | 64 | 47 | 49 | |
| Gross Profit | 247 | 207 | 116 | 51 | 19 | -2 | -12 | -1 | |
| Selling, General and Administrative Excl. Other | 178 | 165 | 132 | 110 | 89 | 58 | 24 | 19 | |
| Research and Development | 297 | 271 | 174 | 119 | 65 | 42 | 19 | 13 | |
| Other Operating Expense | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Income | -226 | -229 | -190 | -178 | -135 | -102 | -55 | -33 | |
| Interest Expense | 9 | 26 | 4 | 4 | 8 | 6 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 23 | 29 | 4 | 3 | 10 | -17 | 0 | 3 | |
| Net Income Before Taxes | -211 | -226 | -189 | -179 | -133 | -125 | -55 | -30 | |
| Income Taxes | -29 | -28 | 1 | 4 | 3 | -8 | 0 | 0 | |
| Consolidated Net Income | -182 | -198 | -190 | -183 | -136 | -117 | -55 | -30 | |
| Net Income From Continuing Operations | -182 | -198 | -190 | -183 | -136 | -117 | -55 | -30 | |
| Net Income | -182 | -198 | -190 | -183 | -136 | -117 | -55 | -30 | |
| EPS (Recurring) | -0.33 | -0.37 | -0.38 | -0.38 | -0.29 | -0.26 | -0.12 | -0.08 | |
| EPS (Basic, Before Extraordinaries) | -0.33 | -0.37 | -0.38 | -0.38 | -0.29 | -0.26 | -0.12 | -0.08 | |
| EPS (Diluted) | -0.33 | -0.37 | -0.38 | -0.38 | -0.29 | -0.26 | -0.12 | -0.08 | |
| EBITDA | -152 | -155 | -152 | -145 | -95 | -108 | -46 | -28 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 62.75 | 61.53 | 28.98 | 10.88 | 8.33 | 89.53 | 129.41 | — | |
| Gross Margin | 36.38 | 34.39 | 26.61 | 20.82 | 9.00 | -3.23 | -34.29 | -2.08 | |
| Operating Margin | -33.28 | -38.04 | -43.58 | -72.65 | -63.98 | -164.52 | -157.14 | -68.75 | |
| Net Margin | -26.80 | -32.89 | -43.58 | -74.69 | -64.45 | -188.71 | -157.14 | -62.50 | |
| Shares Outstanding | 605 | 531 | 496 | 482 | 466 | 452 | 448 | 401 | |
| Market Capitalization | 42,610 | 37,043 | 12,633 | 2,665 | 1,757 | 5,551 | 4,529 | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Beck Peter | CEO | Jul 08 '26 | Sale | 82.86 | 990,960 | 82,115,291 | 1,724,221 | Jul 08 |
| Beck Peter | CEO | Jul 07 '26 | Sale | 84.92 | 1,298,622 | 110,278,981 | 2,715,181 | Jul 08 |
| Beck Peter | CEO | Jul 06 '26 | Sale | 95.33 | 986,197 | 94,015,920 | 4,013,803 | Jul 08 |
| Kampani Arjun | SVP & General Counsel | Jun 18 '26 | Sale | 107.98 | 88,000 | 9,502,240 | 264,705 | Jun 18 |
| Slusky Alexander R | Director | Jun 02 '26 | Sale | 123.60 | 40,000 | 4,944,000 | 334,675 | Jun 05 |
| Klein Frank | Chief Operations Officer | May 28 '26 | Sale | 147.42 | 36,860 | 5,433,997 | 1,006,987 | Jun 01 |
| Clevenger Marvin Bradford | President, Rocket Lab USA, Inc | May 28 '26 | Sale | 146.67 | 3,500 | 513,356 | 473,975 | Jun 01 |
| Kampani Arjun | SVP & General Counsel | May 28 '26 | Sale | 147.43 | 23,804 | 3,509,512 | 352,705 | Jun 01 |
| Slusky Alexander R | Director | May 28 '26 | Sale | 149.40 | 60,000 | 8,964,092 | 374,675 | Jun 01 |
| Kampani Arjun | SVP & General Counsel | May 27 '26 | Sale | 145.13 | 70,000 | 10,158,783 | 376,509 | May 28 |
| Clevenger Marvin Bradford | President, Rocket Lab USA, Inc | May 26 '26 | Sale | 142.57 | 15,549 | 2,216,874 | 477,475 | May 28 |
| Spice Adam C. | Chief Financial Officer | May 26 '26 | Sale | 142.57 | 62,744 | 8,945,631 | 983,049 | May 28 |
| Klein Frank | Chief Operations Officer | May 26 '26 | Sale | 142.57 | 44,390 | 6,328,839 | 1,043,847 | May 28 |
| Kampani Arjun | SVP & General Counsel | May 26 '26 | Sale | 142.57 | 28,668 | 4,087,297 | 446,509 | May 28 |
| Slusky Alexander R | Director | May 12 '26 | Sale | 118.08 | 100,000 | 11,807,635 | 434,675 | May 14 |